ONGOING RESEARCH

As a leading Asthma Program, are active in Environmental Research and routinely present our research annually at National and International meetings.

In addition, we publish our research regularly in multiple peer reviewed journals.

CLINICAL TRIALS:

Title: Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA) 

Brief Description: Comparing Albuterol v. Albuterol + Budesonide 

Sponsor: AstraZeneca 

PI: Sankaran Krishnan 

https://clinicaltrials.gov/study/NCT06307665?term=acadia&rank=1 

  

Title: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (EXHALE-2) 

Brief Description: New Oral Agent for Asthma 

Sponsor: Areteia Therapeutics  

PI: Sankaran Krishnan 

https://clinicaltrials.gov/study/NCT05763121?term=exhale-2&rank=1 

  

Title: Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma (FLASH) 

Brief Description: New Anti-inflammatory for Asthma  

Sponsor: AstraZeneca 

PI: Sankaran Krishnan 

https://clinicaltrials.gov/study/NCT05251259?term=astrazeneca%20flash&rank=1 

  

Title: Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/ Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) 

Brief Description: Biologic for 2-5 Year Olds 

Sponsor: Sanofi 

PI: Sankaran Krishnan 

https://clinicaltrials.gov/study/NCT06191315?term=trekids&rank=1 

  

Title: Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/ Long-acting Beta-agonist (ICS/ LABA) in Comparison to ICS Dose Escalation to High Dose ICS/ LABA in Adolescent and Adult Patients With Uncontrolled Asthma (AIM4:Next Step) 

Brief Description: Biologic Added to Medium Dose Controller Medication v. High Dose Controller Medication Alone 

Sponsor: Regeneron  

PI: Sankaran Krishnan 

https://clinicaltrials.gov/study/NCT06572228?term=R668-AS-2373&rank=1 

  

Title: A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/ Albuterol Sulfate is Effective in Preventing Asthma Exacerbations 

Brief Description: Albuterol v. Albuterol + Fluticasone  

Sponsor: Teva Pharmaceuticals  

PI: Allen Dozor 

https://clinicaltrials.gov/study/NCT06052267?term=FpA-AS-30094&rank=1 

 

STUDENT SCHOLARSHIP and advocacy:

QI: Educational Improvements: Training Multi-Level Learners in Children’s Environmental Health // The NYSCHECK Summer Academy Collaborative

FADD: Food Insecurity and the Addresses of Children

FILE: The Relationship of Food Insecurity and Lead Exposure